Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Barry D.
Contact Barry D., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Atrial and Ventricular Cannulation for Biventricular Circulatory Support With Double‐Ended Centrifugal Pump: In Vitro Evaluation
Background In patients with biventricular heart failure, a biventricular assist device (BVAD) may be necessary for hemodynamic support. BVAD inflows can be established through cannulation of the atrial (AC) and/or ventricular (VC) chambers, but no consensus exists on optimal cannulation techniques. This study aimed to characterize BVAD performance related to cannulation types (AC and VC) using a continuous-flow total artificial heart (CFTAH) as the BVAD.
Improving hydraulic performance of the left atrial assist device using computational fluid dynamics
1 INTRODUCTION Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for approximately half of all HF.1 Although sodium-glucose cotransporter-2 inhibitors, angiotensin receptor/neprilysin inhibitors, and aldosterone antagonists showed some positive effects on HFpEF recently,2-5 there are still fewer treatment options available for these patients than for those with HF with reduced ejection fraction (HFrEF).
Characterization of Left Atrial Assist Device Implantation: Early Results of Ex Vivo Anatomical Assessment
MAIN TEXT This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/aor.14402 Abstract Background The left atrial assist device (LAAD) is a novel pump that was developed specifically for the treatment of heart failure with preserved ejection fraction.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Barry D.
Contact Barry D., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack